Guanhao Biotech Co.,Ltd. (SHE:300238)

China · Delayed Price · Currency is CNY

10.95

+0.65 (6.31%)

Nov 5, 2026, 3:04 PM CST

Guanhao Biotech Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Revenue	344.85	387.75	377.48	404.18	377.29	488.98
Revenue Growth	-12.21%	2.72%	-6.60%	7.13%	-22.84%	11.91%
Gross Profit	258.06	297.18	298.65	315.92	217.69	363.6
Operating Income	13.11	30.46	35.26	39.65	-55.08	68.16
Net Income	13.57	24.35	27.42	31.01	-307.82	73.69
Earnings Per Share	0.05	0.09	0.10	0.12	-1.16	0.28
EPS Growth	-49.03%	-10.00%	-16.67%	-	-	55.56%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Investments	222.53	160.6	106.78	105.14	126.28	159.31
Total Debt	123.94	126.93	108.35	54.67	79.06	151.38
Net Cash (Debt)	98.59	33.68	-1.57	50.47	47.22	7.93
Net Cash Growth	364.23%	-	-	6.88%	495.52%	-
Net Cash Per Share	0.37	0.12	-0.01	0.20	0.18	0.03

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Cash Flow	10.01	71.47	49.55	54.15	70.98	122.39
Capital Expenditures	-29.79	-38.17	-76.2	-53.92	-41.17	-4.71
Free Cash Flow	-19.78	33.3	-26.65	0.23	29.81	117.68
Free Cash Flow Growth	-	-	-	-99.22%	-74.67%	16.59%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Gross Margin	74.83%	76.64%	79.12%	78.16%	57.70%	74.36%
Operating Margin	3.80%	7.85%	9.34%	9.81%	-14.60%	13.94%
Pretax Margin	2.98%	7.04%	7.42%	7.94%	-77.55%	16.78%
Profit Margin	3.94%	6.28%	7.26%	7.67%	-81.59%	15.07%
FCF Margin	-5.74%	8.59%	-7.06%	0.06%	7.90%	24.07%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 5, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
PE Ratio	217.11	150.84	116.44	115.96	-	66.68
Forward PE	-	78.31	78.31	78.31	78.31	78.31
P/FCF Ratio	-	110.27	-	15555.62	91.44	41.75
PS Ratio	8.72	9.47	8.46	8.90	7.23	10.05